1. Proton-Pump Inhibitors to Prevent Gastrointestinal Bleeding -- An Updated Meta-Analysis.
- Author
-
Ying Wang, Parpia, Sameer, Long Ge, Heels-Ansdell, Diane, Honghao Lai, Esfahani, Meisam Abdar, Bei Pan, Alhazzani, Waleed, Schandelmaier, Stefan, Lauzier, Francois, Arabi, Yaseen, Barletta, Jeffrey, Deane, Adam, Finfer, Simon, Williamson, David, Kanji, Salmaan, Møller, Morten H., Perner, Anders, Krag, Mette, and Young, Paul J.
- Subjects
PATIENT safety ,GASTROINTESTINAL hemorrhage ,PEPTIC ulcer ,TREATMENT effectiveness ,META-analysis ,SEVERITY of illness index ,RELATIVE medical risk ,PRE-exposure prophylaxis ,PROTON pump inhibitors ,CONFIDENCE intervals ,CRITICALLY ill patient psychology - Abstract
Background: The goal of this systematic review was to examine the efficacy and safety of proton-pump inhibitors for stress ulcer prophylaxis in critically ill patients. Methods: We included randomized trials comparing proton-pump inhibitors versus placebo or no prophylaxis in critically ill adults, performed meta-analyses, and assessed certainty of evidence using the Grading of Recommendations, Assessment, Development, and Evaluations approach. To explore the effect of proton-pump inhibitors on mortality based on disease severity, a subgroup analysis was conducted combining within-trial subgroup data from the two largest trials and assessed credibility using the Instrument for Assessing the Credibility of Effect Modification Analyses. Results: Twelve trials that enrolled 9533 patients were included. Proton-pump inhibitors were associated with a reduced incidence of clinically important upper gastrointestinal bleeding (relative risk [RR], 0.51 [95% confidence interval (CI), 0.34 to 0.76]; high certainty evidence). Proton-pump inhibitors may have little or no effect on mortality (RR, 0.99 [95% CI, 0.93 to 1.05]; low certainty). Within-trial subgroup analysis with intermediate credibility suggested that the effect of proton-pump inhibitors on mortality may differ based on disease severity. Subgroup results raise the possibility that proton-pump inhibitors may decrease 90-day mortality in less severely ill patients (RR, 0.89; 95% CI, 0.80 to 0.98) and may increase mortality in more severely ill patients (RR, 1.08; 95% CI, 0.96 to 1.20]. Proton-pump inhibitors may have no effect on pneumonia and little or no effect on Clostridioides difficile infection (low certainty). Conclusions: High certainty evidence supports the association of proton-pump inhibitors with decreased upper gastrointestinal bleeding. Proton-pump inhibitors may have little or no effect on mortality, although a decrease in mortality in less severely ill patients and an increase in mortality in more severely ill patients remain possible. (PROSPERO number CRD42023461695.) [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF